ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 397 filers reported holding ENCOMPASS HEALTH CORP in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109 | -99.7% | 1,621 | +118.2% | 0.02% | +90.0% |
| Q3 2022 | $34,000 | -19.0% | 743 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $42,000 | -19.2% | 743 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $52,000 | +6.1% | 743 | 0.0% | 0.01% | +37.5% |
| Q4 2021 | $49,000 | +1533.3% | 743 | +1480.9% | 0.01% | +700.0% |
| Q3 2021 | $3,000 | 0.0% | 47 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -94.4% | 47 | -92.9% | 0.00% | -100.0% |
| Q1 2021 | $54,000 | -46.0% | 661 | -45.7% | 0.01% | -44.4% |
| Q4 2020 | $100,000 | +316.7% | 1,217 | +230.7% | 0.01% | +350.0% |
| Q3 2020 | $24,000 | -69.6% | 368 | -71.0% | 0.00% | -71.4% |
| Q2 2020 | $79,000 | -25.5% | 1,271 | -23.8% | 0.01% | -41.7% |
| Q1 2020 | $106,000 | +171.8% | 1,669 | +229.8% | 0.01% | +200.0% |
| Q4 2019 | $39,000 | -81.6% | 506 | -81.4% | 0.00% | -88.9% |
| Q3 2018 | $212,000 | +98.1% | 2,714 | +72.1% | 0.04% | +111.8% |
| Q2 2018 | $107,000 | – | 1,577 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |